Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 3,090.00
-10.00 (-0.32%)
Jul 21, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 37.69 billion as of July 21, 2026. Its market cap has decreased by -72.14% in one year.
Market Cap
37.69B
Enterprise Value
18.84B
Revenue
475.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,090.00
ChartMarket Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 37.69B, a decrease of -64.53%. That is a compound annual growth rate of -47.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 37.69B | -67.30% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 96.40B |
| MedPacto | 92.37B |
| Amicogen | 82.36B |
| iNtRON Biotechnology | 79.35B |
| ENCell | 72.13B |
| CG Invites | 67.97B |
| Prestige BioPharma | 63.58B |
| ORIENT BIO | 52.47B |